HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 138 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $40,000 | +14.3% | 2,000 | 0.0% | 0.02% | +6.2% |
| Q3 2017 | $35,000 | +34.6% | 2,000 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $26,000 | 0.0% | 2,000 | 0.0% | 0.01% | +7.7% |
| Q1 2017 | $26,000 | +30.0% | 2,000 | 0.0% | 0.01% | +44.4% |
| Q4 2016 | $20,000 | -16.7% | 2,000 | 0.0% | 0.01% | -47.1% |
| Q3 2016 | $24,000 | +26.3% | 2,000 | 0.0% | 0.02% | +21.4% |
| Q2 2016 | $19,000 | -5.0% | 2,000 | 0.0% | 0.01% | -6.7% |
| Q1 2016 | $20,000 | -42.9% | 2,000 | 0.0% | 0.02% | -40.0% |
| Q4 2015 | $35,000 | +25.0% | 2,000 | 0.0% | 0.02% | +13.6% |
| Q3 2015 | $28,000 | -37.8% | 2,000 | 0.0% | 0.02% | -35.3% |
| Q2 2015 | $45,000 | +55.2% | 2,000 | 0.0% | 0.03% | +54.5% |
| Q1 2015 | $29,000 | +52.6% | 2,000 | 0.0% | 0.02% | +15.8% |
| Q4 2014 | $19,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
| First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
| SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
| DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
| Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
| HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
| Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
| Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
| Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |